. . . . . . . . . "31501807" . . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@nl . . . . . . . "R B Lanman" . . "Y K Chae" . "M H Hussain" . . "R J Nagy" . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@en . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@en . . . . "scientific article published on 14 February 2018"@en . . . . . . "6732782" . . . . . . "F J Giles" . . . . "J Odegaard" . . . . . . "K A Collier" . . . . . . "A Fan" . "S Pamarthy" . . "2" . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@nl . . "article scientifique publi\u00E9 en 2018"@fr . . . . "M Cristofanilli" . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en febreru de 2018"@ast . . . . . . . . . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@en . "wetenschappelijk artikel"@nl . . . . . "R Costa" . . . . . . . "S Fairclough" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 14 \u043B\u044E\u0442\u043E\u0433\u043E 2018"@uk . . . . . "T M Kuzel" . . "T Taxter" . . . . . . . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@nl . . . . "S A Abdulkadir" . . . "B A Carneiro" . "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations"@en . "2018-02-14T00:00:00Z"^^ . "10.1200/PO.17.00176" . . . . .